Croatia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Croatia

The Croatian prophylactic medicaments containing insulin market surged to $X in 2022, increasing by 17% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, the total consumption indicated a resilient expansion from 2012 to 2022: its value increased at an average annual rate of +5.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -4.2% against 2020 indices. Prophylactic medicaments containing insulin consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Croatia

Prophylactic medicaments containing insulin exports from Croatia reduced rapidly to X kg in 2022, which is down by -35.9% compared with 2021. Over the period under review, exports, however, enjoyed a significant increase. The growth pace was the most rapid in 2015 when exports increased by 850%. The exports peaked at X kg in 2018; however, from 2019 to 2022, the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports shrank dramatically to $X in 2022. In general, exports, however, enjoyed significant growth. The most prominent rate of growth was recorded in 2016 with an increase of 476%. The exports peaked at $X in 2018; however, from 2019 to 2022, the exports remained at a lower figure.

Exports by Country

Germany (X kg) was the main destination for prophylactic medicaments containing insulin exports from Croatia, accounting for a 53% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Germany exceeded the volume sent to the second major destination, Denmark (X kg), fourfold. Lithuania (X kg) ranked third in terms of total exports with a 13% share.

From 2014 to 2022, the average annual growth rate of volume to Germany totaled +30.2%. Exports to the other major destinations recorded the following average annual rates of exports growth: Denmark (+48.3% per year) and Lithuania (+77.2% per year).

In value terms, the largest markets for prophylactic medicaments containing insulin exported from Croatia were the Czech Republic ($X), Germany ($X) and Lithuania ($X), together comprising 80% of total exports. Slovenia, Denmark and Hungary lagged somewhat behind, together comprising a further 20%.

Hungary, with a CAGR of +95.9%, saw the highest growth rate of the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, surging by 23% against the previous year. Overall, the export price, however, showed a mild setback. The growth pace was the most rapid in 2017 an increase of 43%. The export price peaked at $X per ton in 2014; however, from 2015 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices for the major export markets. In 2022, amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while the average price for exports to Germany ($X per ton) was amongst the lowest.

From 2014 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Hungary (+23.6%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Croatia

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Croatia soared to X tons, rising by 29% compared with 2021 figures. In general, total imports indicated a noticeable expansion from 2012 to 2022: its volume increased at an average annual rate of +4.4% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by -15.8% against 2020 indices. The most prominent rate of growth was recorded in 2013 when imports increased by 41% against the previous year. Imports peaked at X tons in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports expanded sharply to $X in 2022. Over the period under review, total imports indicated a strong increase from 2012 to 2022: its value increased at an average annual rate of +6.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by -0.3% against 2020 indices. The most prominent rate of growth was recorded in 2013 with an increase of 37% against the previous year. Imports peaked at $X in 2020; however, from 2021 to 2022, imports remained at a lower figure.

Imports by Country

In 2022, Denmark (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Croatia, accounting for a 83% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Denmark exceeded the figures recorded by the second-largest supplier, Slovenia (X tons), sixfold.

From 2012 to 2022, the average annual growth rate of volume from Denmark amounted to +14.1%. The remaining supplying countries recorded the following average annual rates of imports growth: Slovenia (+150.1% per year) and Germany (-12.9% per year).

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to Croatia, comprising 79% of total imports. The second position in the ranking was taken by Slovenia ($X), with a 16% share of total imports.

From 2012 to 2022, the average annual rate of growth in terms of value from Denmark stood at +13.3%. The remaining supplying countries recorded the following average annual rates of imports growth: Slovenia (+125.7% per year) and Germany (-6.2% per year).

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, waning by -12.3% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +1.5%. The pace of growth appeared the most rapid in 2021 an increase of 35%. As a result, import price attained the peak level of $X per ton, and then shrank in the following year.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Germany ($X per ton), while the price for Denmark ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Germany (+7.6%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :